The new frontiers of supply chain disruption – and how pharma firms are responding
While supply chain issues are a constant for the pharma industry, the Coronavirus global pandemic sent shockwaves through the sector,…
While supply chain issues are a constant for the pharma industry, the Coronavirus global pandemic sent shockwaves through the sector,…
The path from novel science to a functional business model is rarely a straight one. Besides regulatory hurdles, there remain…
Climate scientists overwhelmingly agree that the global economy must reach net-zero greenhouse gas (GHG) emissions by 2050 to ward off…
This issue is driven by several factors, including the high cost of proprietary medications, the increasing use of the internet…
Any metal contamination in pharmaceutical products is a huge problem. First and foremost, there are possible safety implications for patients…
The expansion at Macungie will offer increased capacity for secondary packaging activities including Vial Labeling, Pre-Filled Syringe (PFS) assembly and labeling, Autoinjector/Pen assembly…
As clinical trials become more complex, the use of electronic clinical outcome assessments (eCOAs) is increasingly important for collecting and…
Epilepsy is a chronic neurological condition characterised by recurring seizures, involuntary movements affecting the body. Idiopathic generalised epilepsy is the…
According to GlobalData, the keyword ‘emissions’ was mentioned 6,272 times across the company filings of pharma organizations in 2023 –…
As the pharma world embraces digitisation with electronic consent (eConsent) forms, wearable devices, and artificial intelligence enhancing the accuracy of…